Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Accounts Payables (2019 - 2025)

Pulmonx (LUNG) has disclosed Accounts Payables for 7 consecutive years, with $6.4 million as the latest value for Q3 2025.

  • Quarterly Accounts Payables rose 40.3% to $6.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Sep 2025, up 40.3% year-over-year, with the annual reading at $3.8 million for FY2024, 155.64% up from the prior year.
  • Accounts Payables for Q3 2025 was $6.4 million at Pulmonx, down from $6.6 million in the prior quarter.
  • The five-year high for Accounts Payables was $6.6 million in Q2 2025, with the low at $1.5 million in Q4 2023.
  • Average Accounts Payables over 5 years is $3.2 million, with a median of $2.9 million recorded in 2023.
  • The sharpest move saw Accounts Payables crashed 40.28% in 2022, then skyrocketed 155.64% in 2024.
  • Over 5 years, Accounts Payables stood at $1.6 million in 2021, then grew by 11.13% to $1.8 million in 2022, then fell by 14.85% to $1.5 million in 2023, then surged by 155.64% to $3.8 million in 2024, then soared by 67.76% to $6.4 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $6.4 million, $6.6 million, and $4.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.